ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 10 filers reported holding ANEBULO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,809 | -24.9% | 4,193 | -42.2% | 0.00% | – |
| Q2 2023 | $17,045 | -22.0% | 7,253 | -3.7% | 0.00% | – |
| Q1 2023 | $21,846 | +23.6% | 7,533 | +3.3% | 0.00% | – |
| Q4 2022 | $17,676 | -11.6% | 7,293 | +2.2% | 0.00% | – |
| Q3 2022 | $20,000 | -47.4% | 7,133 | -2.7% | 0.00% | – |
| Q2 2022 | $38,000 | -28.3% | 7,333 | -1.6% | 0.00% | – |
| Q1 2022 | $53,000 | +8.2% | 7,453 | -4.6% | 0.00% | – |
| Q4 2021 | $49,000 | -2.0% | 7,813 | +2.6% | 0.00% | – |
| Q3 2021 | $50,000 | -5.7% | 7,613 | -2.1% | 0.00% | – |
| Q2 2021 | $53,000 | – | 7,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |